Clinical Trial Update: Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating cabazitaxel plus lapatinib for HER2-positive metastatic breast cancer with intracranial metastases was terminated; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer with Intracranial Metastases

Drugs mentioned

• Jevtana (cabazitaxel) (cabazitaxel)
• Tykerb (lapatinib) (lapatinib)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Metastatic Breast Cancer With Intracranial Metastases | Phase 2 | Status: TERMINATED | Results posted: 2017-06-02